Position in SUPN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,033,800
+$39,800 QoQ
Shares Held
20,000
0.0% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Elmind Capital, LP holds $21,005,300 across 4 Drug Manufacturers - Specialty & Generic names. SUPN ranks #4 (4.9% of the industry book) .
All Filings in SUPN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,033,800 | 20,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $994,000 | 20,000 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||